Teladoc Health, Inc.Watchlist
Teladoc Health Inc (TDOC US): 1Q22 Results Review- Revenue Missed, 2022 Guidance Reduced
Teladoc has reduced 2022 guidance due to unfavorable market dynamics, which will limit near-term upside potential of the shares. Long-term fundamental growth story remains intact.
205 Views, 28 Apr 2022 16:51
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
Unlimited Research Summaries Personalised Alerts Custom Watchlists Company Data & News Events & Webinars
(Paid Plans Only)